HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bedia Akosman Selected Research

kasugamycin

1/2022Kasugamycin Is a Novel Chitinase 1 Inhibitor with Strong Antifibrotic Effects on Pulmonary Fibrosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bedia Akosman Research Topics

Disease

3Pulmonary Fibrosis (Fibrosing Alveolitis)
05/2023 - 01/2019
2Neoplasms (Cancer)
01/2022 - 11/2021
2Neoplasm Metastasis (Metastasis)
01/2022 - 11/2021
2COVID-19
11/2021 - 02/2021
1Glioblastoma (Glioblastoma Multiforme)
01/2023
1Melanoma (Melanoma, Malignant)
01/2022
1Fibrosis (Cirrhosis)
01/2019
1Insulin Resistance
11/2016
1Inflammation (Inflammations)
11/2016

Drug/Important Bio-Agent (IBA)

8ChitinasesIBA
05/2023 - 01/2019
2AntibodiesIBA
01/2022 - 11/2021
2Bispecific AntibodiesIBA
01/2022 - 11/2021
1Proteins (Proteins, Gene)FDA Link
01/2023
1kasugamycinIBA
01/2022
1Immune Checkpoint InhibitorsIBA
01/2022
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2022
1HydrolasesIBA
01/2022
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2022
1LigandsIBA
11/2021
1Glucose (Dextrose)FDA LinkGeneric
11/2016
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2016
1ElementsIBA
11/2016
1Phosphotransferases (Kinase)IBA
11/2016

Therapy/Procedure

1Therapeutics
11/2021